End Cash: The amount of cash held by the company for the given period.
Sanofi (SNY) had End Cash of $8.05B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$47.92B |
|
$6.02B |
|
$14.29B |
|
$33.63B |
|
$39.70B |
|
$8.22B |
|
$-971.73M |
|
$7.25B |
|
$7.52B |
|
$5.95B |
|
$6.01B |
|
$6.08B |
|
$6.26B |
|
$8.22B |
|
$12.10B |
|
2.50B |
|
2.51B |
|
$2.40 |
|
$2.40 |
|
| Balance Sheet Financials | |
$46.08B |
|
$10.92B |
|
$97.62B |
|
$143.70B |
|
$31.56B |
|
$12.76B |
|
$27.90B |
|
$59.45B |
|
$84.25B |
|
$12.82B |
|
$84.25B |
|
2.53B |
|
| Cash Flow Statement Financials | |
$9.83B |
|
$-4.77B |
|
$-6.24B |
|
$9.43B |
|
|
End Cash |
$8.05B |
$-1.37B |
|
-- |
|
$-5.13B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.46 |
|
-- |
|
-- |
|
0.13 |
|
0.21 |
|
70.18% |
|
17.15% |
|
17.15% |
|
25.25% |
|
15.12% |
|
12.55% |
|
$7.95B |
|
-- |
|
-- |
|
-- |
|
0.33 |
|
1.40 |
|
5.27 |
|
69.24 |
|
7.13% |
|
46.89% |
|
4.18% |
|
6.20% |
|
$33.35 |
|
$3.16 |
|
$3.91 |
|